Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-088005

Chief Business Officer sold 3,185 shares at $70.77 ($225,402)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2025-06-16 Sale −3,185 $70.77 $225,402 13,364 D
Open-market sales · 3,185 sh · avg $70.77 · $225,402
Loading xslF345X05/ownership.xml…